Pricing Log in Create free account

Vaxcyte, Inc. (PCVX) vs Summit Therapeutics PLC (SMMT)

Vaxcyte, Inc. and Summit Therapeutics PLC are both Biotechnology companies. Summit Therapeutics PLC is the larger, with a market value of $11.3B against $9.8B — 1.2× the size. Across the 10 metrics below, Summit Therapeutics PLC leads on 6 and Vaxcyte, Inc. on 4.

Valuation

Metric PCVX SMMT Biotechnology median
P/E n/m n/m 10.26
P/S n/m 15,883.80 9.18
P/B 3.28 17.78 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 15,045.51 8.98
Earnings yield (12.20%) (7.78%) (34.89%)
Free cash flow yield (9.89%) (4.11%) (24.52%)

Profitability

Metric PCVX SMMT Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (36.51%) (192.50%) (50.12%)
Return on assets (33.03%) (159.09%) (45.60%)
Return on invested capital (57.30%) 0.00% 0.00%

Growth

Metric PCVX SMMT Biotechnology median
Revenue growth (TTM) — (61.03%) 6.26%
EPS growth (last fiscal year) (48.16%) (364.52%) 29.88%
Revenue growth, 5-year CAGR — (46.49%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PCVX SMMT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.72 6.96 4.89
Net debt to EBITDA 1.71 0.65 1.01

Dividend

Metric PCVX SMMT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PCVX SMMT Biotechnology median
Market cap 9.75b 11.32b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack